Literature DB >> 22477817

Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease.

Grace J Lee1, Risa Cohen, Anthony C Chang, John P Cleary.   

Abstract

We report three cases of angiotensin converting enzyme inhibitor (ACEI) induced nephrotoxicity in preterm infants with congenital heart disease. Patients developed acute renal failure after starting captopril or enalapril at doses commonly prescribed for term neonates. There was no underlying renal disease found in these infants and the acute renal failure was reversible upon discontinuation of the ACEI. Conservative starting doses of ACEI should be used in patients with multiple risk factors for nephrotoxicity. A summary of previously reported ACEI induced renal failure in premature infants and congenital heart disease is included.

Entities:  

Year:  2010        PMID: 22477817      PMCID: PMC3042267     

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  17 in total

1.  Captopril-induced reversible acute renal failure in an infant with coarctation of the aorta.

Authors:  E G Wood; T E Bunchman; R E Lynch
Journal:  Pediatrics       Date:  1991-10       Impact factor: 7.124

2.  Fatal neonatal renal failure due to maternal enalapril ingestion.

Authors:  Srinivas Murki; Praveen Kumar; Sourabh Dutta; Anil Narang
Journal:  J Matern Fetal Neonatal Med       Date:  2005-03

3.  Use of enalapril in neonatal hypertension.

Authors:  J L Schilder; J N Van den Anker
Journal:  Acta Paediatr       Date:  1995-12       Impact factor: 2.299

4.  Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.

Authors:  Sonia Tabacova; Ruth Little; Yi Tsong; Amarilys Vega; Carole A Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-12       Impact factor: 2.890

5.  Enalapril-induced acute renal failure in a newborn infant.

Authors:  Sourabh Dutta; Anil Narang
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

6.  Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.

Authors:  Monika Herbst Gantenbein; Urs Bauersfeld; Oskar Baenziger; Bernhard Frey; Thomas Neuhaus; Felix Sennhauser; Vera Bernet
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

7.  Captopril. Long-term treatment of hypertension in a preterm infant and in older children.

Authors:  L C Hymes; B L Warshaw
Journal:  Am J Dis Child       Date:  1983-03

8.  Efficacy and dosage of enalapril in congenital and acquired heart disease.

Authors:  A M Leversha; N J Wilson; P M Clarkson; A L Calder; M C Ramage; J M Neutze
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

9.  The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure.

Authors:  H Nakamura; M Ishii; T Sugimura; K Chiba; H Kato; T Ishizaki
Journal:  Clin Pharmacol Ther       Date:  1994-08       Impact factor: 6.875

10.  Angiotensin converting enzyme inhibitors and aortic arch obstructive malformations.

Authors:  Kadivar Maliheh; Kiani Abdorrazagh; Kocharian Armen; Shabanian Reza
Journal:  Indian J Med Sci       Date:  2006-10
View more
  6 in total

1.  Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease.

Authors:  Katherine A Lindle; Kim Dinh; Brady S Moffett; W Buck Kyle; Natalie M Montgomery; Susan D Denfield; Jarrod D Knudson
Journal:  Pediatr Cardiol       Date:  2014-03       Impact factor: 1.655

2.  Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients.

Authors:  Payam Ghazi; Brady S Moffett; Antonio G Cabrera
Journal:  Pediatr Cardiol       Date:  2013-12-22       Impact factor: 1.655

3.  Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports.

Authors:  Kevin V Blake; Agnes Saint-Raymond; Cosimo Zaccaria; Francois Domergue; Benjamin Pelle; Jim Slattery
Journal:  Paediatr Drugs       Date:  2016-02       Impact factor: 3.022

4.  Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.

Authors:  Daishi Hirano; Saori Miwa; Daisuke Kakegawa; Chisato Umeda; Yoichi Takemasa; Ai Tokunaga; Kawakami Yuhei; Akira Ito
Journal:  Pediatr Nephrol       Date:  2021-01-19       Impact factor: 3.714

5.  Acute kidney injury in an extremely low birth weight infant with nephrolithiasis: a case report.

Authors:  Rasa Garunkštienė; Rimutė Vaitkevičienė; Ieva Paulavičienė; Nijolė Drazdienė; Rimantė Čerkauskienė
Journal:  Acta Med Litu       Date:  2018

6.  The Aqueous Extract from the Stem Bark of Garcinia lucida Vesque (Clusiaceae) Exhibits Cardioprotective and Nephroprotective Effects in Adenine-Induced Chronic Kidney Disease in Rats.

Authors:  Christelle Stéphanie Sonfack; Elvine Pami Nguelefack-Mbuyo; Jacquy Joyce Kojom; Edwige Laure Lappa; Fernande Petingmve Peyembouo; Christian Kuété Fofié; Tsabang Nolé; Télesphore Benoît Nguelefack; Alain Bertrand Dongmo
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.